Variant NM_000492.4:c.3458T>A


Variant details:
Name NM_000492.4:c.3458T>A
Protein name NP_000483.3:p.(Val1153Glu)
Genomic name (hg19)     chr7:g.117254757T>A    UCSC    
Genomic name (hg38) chr7:g.117614703T>A    UCSC
#Exon/intron exon 21
Legacy Name V1153E
Class disease-causing
Subclass CFTR-RD-causing
WT sequence TGGGCTGTAAACTCCAGCATAGATG T GGATAGCTTGGTAAGTCTTATCATC
Mutant sequence TGGGCTGTAAACTCCAGCATAGATG A GGATAGCTTGGTAAGTCTTATCATC

Other databases:
dbSNP
rs397508567



Pathogenicity predictors:



Response to modulators:


Modulator FDA approval EMA approval in vitro / ex vivo data clinical data
IVAnononono
TEZ-IVA yesnoyesno
ELX-TEZ-IVA yesnoyesno
VNZ-TEZ-DIVA yesnoyesno

clinical and functional data presented above are provided by Vertex


No patient found in CFTR-NGS catalogue


11 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 11
Asymptomatic compound heterozygote 1
CF 1
CFTR-RD8
  • Bronchiectasis  1
  • CBAVD  7
Pending (NBS) 1




Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing

Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
CBAVD 551heterozygoteCF-causing- Undef
CBAVD 6175heterozygoteCF-causing - Trans
CBAVD 5889heterozygoteCF-causing- Undef
CBAVD 4980heterozygoteCF-causing- Undef
CBAVD 1386heterozygote
CBAVD 6545heterozygoteCF-causing- Undef
CBAVD 938heterozygoteCF-causing - Trans
Bronchiectasis 6329heterozygoteCF-causing- Undef
Pending (NBS) 4643heterozygoteCF-causing - Trans
Asymptomatic compound heterozygote 4285heterozygoteVUS2 - Trans
CF 6520heterozygoteCF-causing- Undef


Color code:   non disease-causing <   likely benign <   VUS <   likely pathogenic <   disease-causing



            CFTR variants are clustered into five groups (click here for more details about the classification of variants):
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.



Go to CFTRare